Biomerica Files for FDA EUA for COVID-19 Test
Announcements
Mayo Clinic Joins Clinical Trial — June 1, 2020
Mayo Clinic Joins Clinical Trial — June 1, 2020
Biomerica Receives CE Mark for COVID-19 Test
05/07/2020 Biomerica Receives CE mark for New High-Volume Version of 10 Minute Test for COVID-19 Exposure and Expands International Distribution. New high-volume production test allows Biomerica to expand international distribution to better meet demand of its 10-minute test for coronavirus… Read More
Biomerica Begins Shipping Samples of COVID-19 Test
Biomerica Begins Shipping Samples of COVID-19 Test
Biomerica Announces $2.0 Million Investment
02/26/2020 Biomerica Announces $2.0 Million Investment by Palm Global Small Cap Master Fund IRVINE, CA (February 26, 2020) – Biomerica Inc. (NASDAQ: BMRA) (the “Company” or “Biomerica”) announced today that the Company completed a private placement of $2 million of… Read More
2nd Quarter Financials — January 15, 2020
IRVINE, Calif., Jan. 15, 2020 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA) today reported net sales of $1,596,408 for the three months ended November 30, 2019, compared to $1,500,791 for the same period in the previous year, an increase of… Read More